Document is current
Any future updates will be listed below
-
Authors
Swindle, Taren https://orcid.org/0000-0001-7231-6002
Johnson, Susan L.
Whiteside-Mansell, Leanne
Curran, Geoffrey M.
-
Funding
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (NIH K01 DK110141-01)
- License Information
-
More Information
Article History
Received: 30 June 2017
Accepted: 10 July 2017
First Online: 18 July 2017
Ethics approval and consent to participate
: This protocol was approved by the UAMS Institutional Review Board (IRB 205335). This study will be conducted in accordance with all applicable government regulations and University of Arkansas for Medical Sciences research policies and procedures. Consent was waived by the IRB for EBQI stakeholders but will be collected for teachers and parents participating in the Hybrid III Trial using IRB-approved forms.Waivers of informed consent and Health Insurance Portability and Accountability Act of 1996 authorization were approved for this project as this research involves no more than minimal risk to the subjects; waivers will not adversely affect the rights and welfare of the subjects; and the research could not practicably be carried out with the waiver.
: Not applicable.
: Dr. Leanne Whiteside-Mansell, Dr. Taren Swindle, and UAMS have a financial interest in the technology (WISE) discussed in this presentation/publication. These financial interests have been reviewed and approved in accordance with the UAMS conflict of interest policies. The other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
